Invion Limited (IVX)

Overview

Invion Limited is a clinical-stage life-sciences company based in Melbourne, Australia, focusing on the innovative application of Photosoft technology for the treatment of a wide array of diseases. Founded in 2000, the company dives deep into the realm of therapeutic research, with a strong emphasis on cancers, atherosclerosis, and infectious diseases. Through its groundbreaking work, Invion aims to develop effective treatments that can offer new hope and options for patients facing these serious health challenges. The company's approach includes significant collaborations with esteemed research institutions like the Hudson Institute of Medical Research and the Peter MacCallum Cancer Centre. These partnerships underscore Invion's commitment to advancing its research and development efforts in order to bring transformative therapies from the lab bench to the bedside.

Products and Services

• IVX-PDT

  At the core of Invion's product pipeline is IVX-PDT, a photosensitizer agent designed for the treatment of various cancers. This innovative therapy is at the forefront of Invion's efforts to combat skin cancers and a range of solid tumors, including lung, prostate, ovarian, anogenital, and mesothelioma cancers. IVX-PDT stands as a testament to the company's dedication to developing cutting-edge therapeutic options that can potentially revolutionize cancer treatment.

• Research Collaborations

  Invion maintains a pivotal role in advancing cancer therapy through its active research and development collaborations. One such partnership is with the Hudson Institute of Medical Research, aimed at developing a novel photosensitizer for effectively treating a broad spectrum of cancers. Another significant collaboration is with the Peter MacCallum Cancer Centre, focusing on pre-clinical and in-vitro studies to explore the efficacy of IVX-PDT Photodynamic therapy specifically for ano-genital cancers, including penile and anal cancers. These collaborative efforts not only extend the potential impact of Invion's technology but also highlight the company's commitment to exploring and establishing innovative treatments across various cancer types.